REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Extrawell Pharmaceutical Holdings Limited (Hong Kong SAR, China)

Main Activities: Chemical Manufacturing | Pharmaceutical and Medicine Manufacturing
Full name: Extrawell Pharmaceutical Holdings Limited Profile Updated: July 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

The principal activities are the marketing and distribution of pharmaceutical products to customers in the People＇s Republic of China (the ‘PRC＇); the development, manufacture and sales of pharmaceutical products in the PRC; the business of commercial exploitation and development of genome-related technology; and the development and commercialisation of oral insulin products.

Headquarters
Suites 2206-08, 22nd Floor, Devon House, Taikoo Place, 979 King＇s Road, Quarry Bay, Hong Kong
Hong Kong; Hong Kong;

Contact Details: Purchase the Extrawell Pharmaceutical Holdings Limited report to view the information.

Website: http://www.extrawell.com.hk

Basic Information
Total Employees:
Purchase the Extrawell Pharmaceutical Holdings Limited report to view the information.
Outstanding Shares:
Purchase the Extrawell Pharmaceutical Holdings Limited report to view the information.
Registered Capital:
Purchase the Extrawell Pharmaceutical Holdings Limited report to view the information.
Financial Auditors:
Purchase the Extrawell Pharmaceutical Holdings Limited report to view the information.
Incorporation Date:
December 08, 1998
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
7.94%
Purchase this report to view the information.
6.28%
Subsidiaries
Changchun Extrawell Pharmaceutical Co., Ltd. (China)
100%
Extrawell (BVI) Limited
100%
Extrawell Enterprises Limited
100%
Company Performance
Financial values in the chart are available after Extrawell Pharmaceutical Holdings Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HKD. Absolute financial data is included in the purchased report.
Net sales revenue
-18.57%▼
Total operating revenue
-20.97%▼
Operating profit (EBIT)
N/A
EBITDA
-99.53%▼
Net Profit (Loss) for the Period
N/A
Total assets
-10.91%▼
Total equity
-13.18%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
2.77%▲
Quick Ratio
0.23%▲
Cash Ratio
-0.32%▼

Similar companies

China Resources Pharmaceutical Group Ltd
 
Fosun International Limited
Kingboard Holdings Limited
 
CSPC Pharmaceutical Group Limited
Fufeng Group Limited
 
Sino Biopharmaceutical Limited
Smartac International Holdings Limited
 
GT Group Holdings Limited (Hong Kong) (高富集团控股有限公司 (香港))
Hao Wen Holdings Limited
 
SoftMedx Healthcare Limited
New Ray Medicine International Holding Limited
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo